NATO MULTIMEDIA ACCOUNT

Access NATO’s broadcast-quality video content free of charge

Register

Create an account

Create an account

Check your inbox and enter verification code

We have sent a verification code to your email address. . Enter the code to verify your account. This code will expire in 30 minutes.
Verification code

Didn't receive a code? Send new Code

You have successfully created your account

From now on you can download videos from our website

Subscribe to our newsletter

If you would also like to subscribe to the newsletter and receive our latest updates, click on the button below.

Reset password

Enter the email address you registered with and we will send you a code to reset your password.

Log in or Create an account
Reset password
Check your inbox and enter verification code
We have sent a verification code to your email address. Enter the code to verify your account. This code will expire in 30 minutes.
Verification code

Didn't receive a code? Send new Code

Create a new password

The password must be at least 12 characters long, no spaces, include upper/lowercase letters, numbers and symbols.

Your password has been updated

Click the button to return to the page you were on and log in with your new password.

NATO Allies broke new ground by adopting the first international strategy to govern the responsible development and use of biotechnologies and human enhancement technologies at a meeting of Allied Defence Ministers in February. On Friday (12 April 2024), NATO released a public version of the strategy.

Faced with the exponential growth of biotech breakthroughs and their anticipated impact on defence and security, NATO has positioned itself as an ethical leader on biotech and human enhancement technologies by adopting an informed, value-based and gender-aware strategy. 

The aim is to embrace these emerging solutions lawfully and responsibly, while developing a trusted relationship with innovators and the public and protecting the Alliance against misuse of these technologies by strategic competitors and potential adversaries. Implementation of the strategy will be carried out in full respect of international law and existing protocols and practices, especially for bioethics. Application of biotech-related solutions will be in line with NATO’s defensive nature. It can range from the possible use of biosensors to enhance the detection of biological and chemical threats; to the development of health tech wearables; and other biomaterials that can help protect and heal servicemen and women. 

Expert research on opportunities and challenges linked to such an application will start in the months to come.

Biotechnology and Human Enhancement technologies were identified as a priority emerging, disruptive technology in 2019.